sphingosyl-beta-glucoside and Smoldering-Multiple-Myeloma

sphingosyl-beta-glucoside has been researched along with Smoldering-Multiple-Myeloma* in 1 studies

Reviews

1 review(s) available for sphingosyl-beta-glucoside and Smoldering-Multiple-Myeloma

Article	Year
Determination of the target of monoclonal immunoglobulins: a novel diagnostic tool for individualized MGUS therapy, and prevention and therapy of smoldering and multiple myeloma. Frontiers in immunology, 2023, Volume: 14 Subsets of patients diagnosed with a monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM) or multiple myeloma (MM), present with a monoclonal immunoglobulin (Ig) specific for an infectious pathogen, including hepatitis C and B viruses (HCV, HBV), Topics: Antibodies, Monoclonal; Hepatitis C; Humans; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Paraproteins; Smoldering Multiple Myeloma	2023

Article

Year

Determination of the target of monoclonal immunoglobulins: a novel diagnostic tool for individualized MGUS therapy, and prevention and therapy of smoldering and multiple myeloma.

Frontiers in immunology, 2023, Volume: 14

Subsets of patients diagnosed with a monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM) or multiple myeloma (MM), present with a monoclonal immunoglobulin (Ig) specific for an infectious pathogen, including hepatitis C and B viruses (HCV, HBV),

Topics: Antibodies, Monoclonal; Hepatitis C; Humans; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Paraproteins; Smoldering Multiple Myeloma

2023